通过D2受体显像发现的恶性催乳素瘤。 - Suppr

Suppr

超能文献

Malignant prolactinoma discovered by D2 receptor imaging.

作者信息

Petrossians P, de Herder W, Kwekkeboom D, Lamberigts G, Stevenaert A, Beckers A

机构信息

Department of Endocrinology, University Hospital, Liege, Belgium.

出版信息

J Clin Endocrinol Metab. 2000 Jan;85(1):398-401. doi: 10.1210/jcem.85.1.6253.

DOI:10.1210/jcem.85.1.6253

PMID:10634416

Abstract

摘要

相似文献

Malignant prolactinoma discovered by D2 receptor imaging.通过D2受体显像发现的恶性催乳素瘤。

J Clin Endocrinol Metab. 2000 Jan;85(1):398-401. doi: 10.1210/jcem.85.1.6253.

Comparison of iodine-123 epidepride and iodine-123 IBZM for dopamine D2 receptor imaging in clinically non-functioning pituitary macroadenomas and macroprolactinomas.碘-123 表哌立得与碘-123 IBZM 在临床无功能垂体大腺瘤和大泌乳素瘤多巴胺 D2 受体显像中的比较。

Eur J Nucl Med. 1999 Jan;26(1):46-50. doi: 10.1007/s002590050358.

Dopamine D2 receptor imaging in pituitary adenomas using iodine-123-epidepride and SPECT.使用碘-123-表阿朴吗啡和单光子发射计算机断层扫描对垂体腺瘤进行多巴胺D2受体成像。

J Nucl Med. 1996 Dec;37(12):1931-7.

In vivo visualization of pituitary dopaminergic receptors by iodine-123 methoxybenzamide (IBZM) correlates with sensitivity to dopamine agonists in two patients with macroprolactinomas.通过碘-123甲氧基苄胺（IBZM）对两名大泌乳素瘤患者的垂体多巴胺能受体进行体内可视化，这与对多巴胺激动剂的敏感性相关。

J Clin Endocrinol Metab. 1995 Aug;80(8):2523-5. doi: 10.1210/jcem.80.8.7629253.

Visual vignette.视觉小品文。

Endocr Pract. 2004 May-Jun;10(3):294. doi: 10.4158/EP.10.3.294.

Iodine-123-IBZM-SPECT: studies in 15 patients with pituitary tumors.碘-123-碘苄胍单光子发射计算机断层扫描：15例垂体瘤患者的研究

J Neural Transm Gen Sect. 1994;97(3):235-44. doi: 10.1007/BF02336144.

Somatostatin receptor scintigraphy of a patient with a giant invasive prolactinoma.一名巨大侵袭性催乳素瘤患者的生长抑素受体闪烁扫描术

Nuklearmedizin. 1999;38(2):66-7.

Correlation of scintigraphic results using 123I-methoxybenzamide with hormone levels and tumor size response to quinagolide in patients with pituitary adenomas.垂体腺瘤患者中使用123I-甲氧基苯甲酰胺的闪烁扫描结果与激素水平及对喹高利特的肿瘤大小反应的相关性。

J Clin Endocrinol Metab. 1998 Jan;83(1):248-52. doi: 10.1210/jcem.83.1.4493.

Dopamine agonist therapy of clinically non-functioning pituitary macroadenomas. Is there a role for 123I-epidepride dopamine D2 receptor imaging?临床无功能垂体大腺瘤的多巴胺激动剂治疗。123I-表阿朴吗啡多巴胺D2受体显像有作用吗？

Eur J Endocrinol. 2006 Nov;155(5):717-23. doi: 10.1530/eje.1.02281.

Dopamine D2 receptor brain imaging in the neonatal period using 123I-IBZM SPECT.新生儿期使用123I-碘苄胍单光子发射计算机断层扫描进行多巴胺D2受体脑成像。

J Nucl Med. 1999 Dec;40(12):2126-7.

引用本文的文献

Macroprolactinoma with secondary resistance to dopamine agonists: a case report and review of the literature.大催乳素腺瘤继发于多巴胺激动剂抵抗：病例报告及文献复习。

J Med Case Rep. 2023 Mar 17;17(1):96. doi: 10.1186/s13256-023-03820-5.

Surgery, Octreotide, Temozolomide, Bevacizumab, Radiotherapy, and Pegvisomant Treatment of an AIP Mutation‒Positive Child.手术、奥曲肽、替莫唑胺、贝伐单抗、放疗和培维索孟治疗 AIP 突变阳性儿童。

J Clin Endocrinol Metab. 2019 Aug 1;104(8):3539-3544. doi: 10.1210/jc.2019-00432.

Familial isolated pituitary adenomas (FIPA) and the pituitary adenoma predisposition due to mutations in the aryl hydrocarbon receptor interacting protein (AIP) gene.家族性孤立性垂体腺瘤（FIPA）和由于芳香烃受体相互作用蛋白（AIP）基因突变引起的垂体腺瘤易感性。

Endocr Rev. 2013 Apr;34(2):239-77. doi: 10.1210/er.2012-1013. Epub 2013 Jan 31.

The epidemiology of prolactinomas.催乳素瘤的流行病学

Pituitary. 2005;8(1):3-6. doi: 10.1007/s11102-005-5079-0.

Pituitary carcinoma: diagnosis and treatment.

Endocrine. 2005 Oct;28(1):115-21. doi: 10.1385/ENDO:28:1:115.

Progression on metastatic neuroendocrine carcinoma from a recurrent prolactinoma: a case report.复发性泌乳素瘤进展为转移性神经内分泌癌：一例报告

J Clin Pathol. 2002 Feb;55(2):148-51. doi: 10.1136/jcp.55.2.148.

文献检索

告别复杂PubMed语法，用中文像聊天一样搜索，搜遍4000万医学文献。AI智能推荐，让科研检索更轻松。

立即免费搜索

文件翻译

保留排版，准确专业，支持PDF/Word/PPT等文件格式，支持 12+语言互译。

免费翻译文档

深度研究

AI帮你快速写综述，25分钟生成高质量综述，智能提取关键信息，辅助科研写作。

立即免费体验